scholarly article | Q13442814 |
P356 | DOI | 10.1016/S1472-6483(10)61004-8 |
P698 | PubMed publication ID | 16569320 |
P2093 | author name string | R S Jeyendran | |
Carolyn B Coulam | |||
Roumen Roussev | |||
Laurence A Fishel | |||
P2860 | cites work | Evolutionary families of peptidases | Q24527684 |
Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C | Q24563608 | ||
Recurrent implantation failure in assisted reproduction: how to counsel and manage. B. Treatment options that have not been proven to benefit the couple | Q28192087 | ||
A functional overlap of plasminogen and MMPs regulates vascularization during placental development | Q28507163 | ||
Differences in the implantation rates of rat embryos developed in vivo and in vitro: possible role for plasminogen activators | Q28568660 | ||
Mutation in blood coagulation factor V associated with resistance to activated protein C. | Q34340007 | ||
Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction | Q34545496 | ||
Embryo-maternal signalling: how the embryo starts talking to its mother to accomplish implantation | Q35098942 | ||
Inherited Thrombophilia: Impact on Human Reproduction | Q35542242 | ||
Recurrent implantation failure in assisted reproduction: how to counsel and manage. A. General considerations and treatment options that may benefit the couple | Q36263766 | ||
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 are key regulators of extracellular matrix degradation by mouse embryos. | Q40810453 | ||
Role of embryonic factors in human implantation | Q41068444 | ||
A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity | Q42540064 | ||
Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population | Q43563872 | ||
Thrombophilic gene mutations and recurrent spontaneous abortion: prothrombin mutation increases the risk in the first trimester | Q43707708 | ||
Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia | Q43832942 | ||
Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study | Q44420380 | ||
Array-based multiplex analysis of candidate genes reveals two independent and additive genetic risk factors for myocardial infarction in the Finnish population | Q47700887 | ||
Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages | Q47753006 | ||
The 4G/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications | Q47866791 | ||
Factor V Leiden mutation as a risk factor for recurrent pregnancy loss | Q47978297 | ||
Polycystic ovary syndrome, infertility, familial thrombophilia, familial hypofibrinolysis, recurrent loss of in vitro fertilized embryos, and miscarriage. | Q51554599 | ||
Activated protein C resistance and factor V Leiden mutation can be associated with first-as well as second-trimester recurrent pregnancy loss. | Q54060706 | ||
Implantation failure and immunotherapy | Q54572684 | ||
Increased Platelet Aggregability Associated With Platelet GPIIIa Pl A2 Polymorphism | Q57629024 | ||
Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage | Q61842465 | ||
Cytokines in Implantation | Q61989584 | ||
Inherited thrombophilia and in vitro fertilization implantation failure | Q63439563 | ||
Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde | Q70908819 | ||
The number of dichorionic twin pregnancies is reduced by the common MTHFR 677C-->T mutation | Q73247170 | ||
Factor V leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages | Q73401841 | ||
Plasminogen activators and inhibitors are transcribed during early macaque implantation | Q73423920 | ||
Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation | Q73590611 | ||
Platelet glycoprotein IIb/IIIa Pl(A2)/Pl(A2) homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men: the Copenhagen City Heart Study | Q73837005 | ||
Selection pressure for the factor-V-Leiden mutation and embryo implantation | Q77053489 | ||
Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss | Q77849792 | ||
Polymorphisms of genes affecting thrombosis and risk of myocardial infarction | Q78676262 | ||
Altered trophoblast functions in implantation-defective mouse embryos | Q93606234 | ||
P433 | issue | 3 | |
P921 | main subject | thrombophilia | Q1570013 |
P304 | page(s) | 322-327 | |
P577 | publication date | 2006-03-01 | |
P1433 | published in | Reproductive BioMedicine Online | Q15762964 |
P1476 | title | Multiple thrombophilic gene mutations are risk factors for implantation failure | |
P478 | volume | 12 |